Ticker Sage

Form 4 · JNJ

Johnson & Johnson Chief Legal Officer Elizabeth Forminard reports selling 13,072 shares

Elizabeth Forminard, Johnson & Johnson's EVP, Chief Legal Officer, filed a Form 4 on Nov 13, 2026 at 4:54 PM ET reporting transactions on Nov 12, 2026.

The filing reports 13,072 shares in an open-market or private sale (code S) at $284.39, about $3.7 million in total; and 13,072 shares in an exercise or conversion of a derivative security (code M).

The filing does not indicate that the sales were made under a Rule 10b5-1 trading plan.

After these transactions, the filing lists 16,994 shares held directly.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-12MCommon Stock13,072$151.41Acquired30,066Direct
2026-11-12SCommon Stock13,072$284.39Disposed16,994Direct
2026-11-12MEmployee Stock Options (Right to Buy) (derivative)13,072Disposed0Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Johnson & Johnson company file → · More Johnson & Johnson filings

Disclosures

Editor holdings in JNJ
The editor holds no position in Johnson & Johnson (JNJ). As of Nov 11, 2026.
Last updated
Nov 13, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold JNJ.